ASGCT Advancing Cell + Gene Therapies for Cancer (Philadelphia, PA, Oct 15-16, 2025)
PackGene is excited to participate in the ASGCT Advancing Cell + Gene Therapies for Cancer, taking place October 15–16, 2025 in Philadelphia. This 1.5-day event brings together scientists and clinicians to explore pioneering approaches in oncolytic viruses, next-generation cell therapies, and integrated viral and cellular platforms to enhance immune responses and accelerate progress in cancer treatment.
At the meeting, PackGene will present two scientific posters focused on novel AAV capsids for tissue-specific gene delivery, highlighting our commitment to advancing precision gene therapies.
In addition to our poster research, PackGene offers comprehensive capabilities in:
We look forward to connecting with researchers, clinicians, and trainees to explore collaborations, discuss our innovative platforms, and advance the field of cancer gene and cell therapies.
Details
📅 Date: Oct. 15-16, 2025
📍 Venue: Philadelphia Marriott Downtown
📨 Contact: info@packgene.com
Poster
- 1281 Novel AAV capsids to deliver gene therapy to CNS, retina, muscle, kidney, and t-cells
- 1282 Development of Liver-De-targeted AAV Capsids for Muscle-Selective Gene Delivery and Therapeutic Rescue in DMD
Related Service
-
GMP Plasmid
- cGMP plasmid production up to 200L with flexible scales
- Strict contamination control using isolated lines and single-use tech
- Over 10 years of expert manufacturing with full process support
-
Viral Vector GMP Manufacturing
- Cost-effective, clinic-ready AAV production with scalable platforms
- Robust tech transfer and regulatory-compliant quality systems
- Proven expertise across clinical and commercial manufacturing stages
